Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Idera initiates phase I/II cancer study
HYB2055 (also known as IMO-2055 or IMOxine) is Idera’s lead toll-like receptor 9 (TLR9) agonist for the treatment of cancer. The phase I/II trial is a two-phase study
HYB2055 (also known as IMO-2055 or IMOxine) is Idera’s lead toll-like receptor 9 (TLR9) agonist for the treatment of cancer. The phase I/II trial is a two-phase study
Diclofenac is marketed by Novartis as Cataflam/Voltaren and a topical diclofenac product is sold by SkyePharma under the brand name Solaraze. Formulations of topical diclofenac, a non-steroidal anti-inflammatory
Under the terms of the settlement agreement, Abbott will pay CAT $255 million, which CAT will pay to its licensors, the Medical Research Council (MRC), Scripps Institute and
The result follows the FDA’s acceptance of Insumed’s response to an approvable letter issued by the authority seeking further clarification. The submission is being made for iPlex, a
The US dose finding study for PCK3145, Procyon’s non-toxic therapeutic peptide for the treatment of advanced prostate cancer, is going well. With four patients remaining to be enrolled
According to the American Association of Clinical Endocrinologists’ (AACE) approximately 1.2 million people in Texas are diagnosed with diabetes. Type 2 diabetes, the most common form of the
The application applies to the use of Rituxan (rituximab) in previously-untreated patients with intermediate grade or aggressive non-Hodgkin’s lymphoma. The treatment would be used in combination with anthracycline-based
Schering AG has been working with Cenix, a spin-off from the European Molecular Biology Laboratory and the Max Planck Institute, completing pilot studies using Cenix’s technology to seek
Production of influenza vaccine using cell-culture technology may offer advantages over traditional manufacturing methods by eliminating the dependence on chicken eggs for production. The removal of egg supply
Under the terms of the agreement, Siemens will offer its health system customers access to RxHub’s pithily titled ‘Medication and Eligibility Delivery Solution’ (MEDS). The system, essentially a